Rapid Bioassay for Detection of Thyroid-Stimulating Antibodies Using Cyclic Adenosine Monophosphate-Gated Calcium Channel and Aequorin
暂无分享,去创建一个
M. Iida | A. Miyauchi | A. Ide | S. Morita | Mitsuru Ito | E. Nishihara | Naohiro Araki | N. Amino | J. Saito | T. Nishikawa | K. Katsuragi
[1] A. Miyauchi,et al. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. , 2014, Thyroid : official journal of the American Thyroid Association.
[2] B. Rapoport,et al. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. , 2013, Thyroid : official journal of the American Thyroid Association.
[3] P. Vitti,et al. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease. , 2012, The Journal of clinical endocrinology and metabolism.
[4] G. Kahaly,et al. Bioassays for TSH-receptor autoantibodies: an update. , 2010, Autoimmunity reviews.
[5] G. Kahaly,et al. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. , 2010, The Journal of clinical endocrinology and metabolism.
[6] A. Miyauchi,et al. Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. , 2008, Thyroid : official journal of the American Thyroid Association.
[7] A. Mithöfer,et al. Aequorin-based measurements of intracellular Ca2+-signatures in plant cells , 2002, Biological Procedures Online.
[8] N. Morgenthaler,et al. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. , 2007, The Journal of clinical endocrinology and metabolism.
[9] D. Weightman,et al. A new assay for thyrotropin receptor autoantibodies. , 2004, Thyroid : official journal of the American Thyroid Association.
[10] T. Pozzan,et al. Intracellular targeting of the photoprotein aequorin: A new approach for measuring, in living cells, Ca2+ concentrations in defined cellular compartments , 2004, Cytotechnology.
[11] M. Detheux,et al. Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. , 2002, Receptors & channels.
[12] A. Nagata,et al. Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentrations and porcine thyroid cells. , 1999, Endocrine journal.
[13] N. Morgenthaler,et al. Development of a luminescent bioassay for thyroid stimulating antibodies. , 1999, The Journal of clinical endocrinology and metabolism.
[14] Watson,et al. A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease , 1998, Clinical endocrinology.
[15] N. Amino,et al. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. , 1997, Thyroid : official journal of the American Thyroid Association.
[16] M. L. Ruiz,et al. Cloning and characterization of an olfactory cyclic nucleotide-gated channel expressed in mouse heart. , 1996, Journal of molecular and cellular cardiology.
[17] B. Rapoport,et al. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. , 1989, Biochemical and biophysical research communications.
[18] K. Ichihara,et al. EVALUATION OF TSH RECEPTOR ANTIBODY BY ‘NATURAL IN VIVO HUMAN ASSAY’ IN NEONATES BORN TO MOTHERS WITH GRAVES’ DISEASE , 1989, Clinical endocrinology.
[19] Y. Iwatani,et al. IN‐VITRO CONVERSION OF BLOCKING TYPE ANTI‐TSH RECEPTOR ANTIBODY TO THE STIMULATING TYPE BY ANTI‐HUMAN IgG ANTIBODIES , 1987, Clinical endocrinology.
[20] P. Spiller,et al. Blood flow. , 1985, European heart journal.